The Wall Street Journal: Pfizer asks FDA to authorize its 3-dose COVID vaccine for children under 5

The companies said last month that three doses of the shot were 80% effective at preventing symptomatic COVID-19 and generated a robust immune response in children ages 6 months to 5 years old.

Read More

Previous post A vital climate fighter in Biden administration heads toward an uncertain Senate reconfirmation vote
Next post A Lack Of Consumer Portability And Choice Are Negatively Affecting The Mobile Experience: Part 2